Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.

Brillac C, Sémiond D, Oprea C, Baruchel A, Zwaan CM, Nguyen L

Open source

DOI
10.1007/s00280-025-04832-2
Published
2025 Dec 3
Container
Cancer chemotherapy and pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-025-04832-2,
  title = {Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.},
  author = {Brillac C and Sémiond D and Oprea C and Baruchel A and Zwaan CM and Nguyen L},
  year = {2025},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-025-04832-2},
  url = {https://doi.org/10.1007/s00280-025-04832-2}
}

RIS

TY  - JOUR
TI  - Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.
AU  - Brillac C
AU  - Sémiond D
AU  - Oprea C
AU  - Baruchel A
AU  - Zwaan CM
AU  - Nguyen L
PY  - 2025
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-025-04832-2
UR  - https://doi.org/10.1007/s00280-025-04832-2
ER  - 

APA

C, B., D, S., C, O., A, B., CM, Z., & L, N. (2025). Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-025-04832-2

Source records